Skip to main content
Fig. 1 | Trials

Fig. 1

From: FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial

Fig. 1

Flow chart of FANTASTIC study. The FANTASTIC study consists of two phases: four-parallel double-blind period to investigate the reno-protective effect of fimasartan and two-parallel open-label period for prognosis in accordance with target BP. a Standard BP control group (systolic BP < 140 mmHg). b Strict BP control group (systolic BP < 130 mmHg). FIM fimasartan, LOS losartan, CCB calcium channel blocker, ACR albumin–creatinine ratio, CV cardiovascular, SBP systolic blood pressure

Back to article page

Trials

ISSN: 1745-6215